Suchergebnisse - "Klausmann, Martine"

PubPharm (8)

1

Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7) : part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial

enthalten in: The Lancet. Haematology | 2022

von Goldschmidt, H. | Mai, E. | Bertsch, U. | +123

CommentIn: Lancet Haematol. 2022 Nov;9(11):e798-e799. - PMID 36328036

2

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1) : an open-label, multicentre, randomised, phase 3 trial

enthalten in: The Lancet. Haematology | 2022

von Dimopoulos, M. | Richardson, P. | Bahlis, N. | +124

CommentIn: Lancet Haematol. 2022 Jun;9(6):e386-e387. - PMID 35550059

3

Disease management of patients with immune thrombocytopenia-results of a representative retrospective survey in Germany

enthalten in: Annals of hematology | 2020

von Kubasch, A. | Kisro, J. | Heßling, J. | +6

4

Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma

enthalten in: The New England journal of medicine | 2019

von Facon, T. | Kumar, S. | Plesner, T. | +128

CommentIn: N Engl J Med. 2019 May 30;380(22):2172-2173. - PMID 31141641

5

Impact of performance status and transfusion dependency on outcome of patients with myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia treated with azacitidine (PIAZA study)

enthalten in: European journal of haematology | 2018

von Wehmeyer, J. | Zaiss, M. | Losem, C. | +9

6

Survival of non-transplant patients with multiple myeloma in routine care differs from that in clinical trials-data from the prospective German Tumour Registry Lymphatic Neoplasms

enthalten in: Annals of hematology | 2018

von Knauf, W. | Aldaoud, A. | Hutzschenreuter, U. | +6

7

Multiple Myeloma Treatment in Real-world Clinical Practice : Results of a Prospective, Multinational, Noninterventional Study

enthalten in: Clinical lymphoma, myeloma & leukemia | 2018

von Mohty, M. | Terpos, E. | Mateos, M. | +130

8

Effect of ABCG2, OCT1, and ABCB1 (MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI Subtrial

enthalten in: Clinical lymphoma, myeloma & leukemia | 2018

von Rinaldetti, S. | Pfirrmann, M. | Manz, K. | +29

1
[1]